The FDA authorizes a Pfizer booster shot for children ages 12 to 15

The Food and Drug Administration has authorized the use of a Pfizer-BioNTech booster in adolescents 12 to 15 years old. The agency on Monday also shortened the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose to five months from six.Finally, the FDA allowed for a third dose of vaccine in immunocompromised children 5 to 11 years of age.
NPR, Read More.
© 2016 Mississippi Health Advocacy Program